An interventional study of KG1 and KG2 in Myopia, sponsored by Kubota Vision Inc.. Not yet recruiting. Open to participants aged 8 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-07.
Sponsored by Kubota Vision Inc. (part of Kubota Pharmaceutical Holdings Co., Ltd.) · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study will assess the optimal performance characteristics of optical defocus on transient changes in axial length with Kubota Glass, using a randomized, double-masked, 5-treatment, 5-period crossover design with contralateral eye control.
1,162 studies on the registry are indexed under Myopia; 228 are open to participants now.
This study's planned enrollment of 35 is below the median of 79 across 926 interventional studies indexed under Myopia.
Browse Myopia studies →Kubota Vision Inc. is the lead sponsor of 21 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Device: KG1 · Device: KG2 · Device: KG3 · Device: KG4 · Device: KG5
Unique Kubota Glass optical defocus parameter
Unique Kubota Glass optical defocus parameter
Unique Kubota Glass optical defocus parameter
Unique Kubota Glass optical defocus parameter
Unique Kubota Glass optical defocus parameter
Axial length
Time frame: 1 hour
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Jul 2026; primary completion for Dec 2026, 4 months later.
Of 234 industry-sponsored interventional studies with no phase under Myopia, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 24. This study's planned 4 months is below that.
Counting every sponsor, half of 434 studies reached it within 14 months; a quarter within 3 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.